What are Vir Biotechnology, Inc.'s profit margins?

Vir Biotechnology, Inc. (VIR) runs a 96.1% gross margin and a -720.8% operating margin, with a -676.0% net margin.

Where do Vir Biotechnology, Inc.'s ratios come from?

Every ratio is computed from Vir Biotechnology, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Vir Biotechnology, Inc. VIR Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Operating margin	-720.8%+2,379pp	-699.2%+92.1pp	-3,253.6%-2,479pp	-3,191.7%-2,476pp	-3,099.7%-2,320pp
Net margin	-676%+2,093pp	-638.9%+64.5pp	-2,963.5%-2,285pp	-2,895.9%-2,284pp	-2,769%-2,091pp
Returns
Return on equity	-47.7%-3.1pp	-45.7%-7.6pp	-49.1%-12.5pp	-46.2%-16.4pp	-44.6%-13.9pp
Return on invested capital	-67.6%-10.3pp	-61.8%-12.5pp	-60.7%-10.4pp	-61.4%-16.0pp	-57.2%-12.0pp
Efficiency
Asset turnover	0.1×0.0×	0.1×0.0×	0×0.0×	0×0.0×	0×0.0×
Liquidity
Current ratio	7.1×+0.3×	5.5×-3.2×	7.3×-1.7×	7×-5.5×	6.8×-6.1×
Leverage
Debt-to-equity	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Per Share
Book value per share	$5.52-27.4%	$5.52-34.6%	$5.73-36.9%	$6.84-35.0%	$7.59-33.6%
Valuation
Market capitalization	$1.43B+61.1%	$838.92M-17.0%	$793.21M-22.3%	$728.51M-39.5%	$888.69M-35.2%
Price / sales	21.9×-20.7×	12.2×-1.4×	47×+34.1×	38.3×+23.1×	42.6×+25.4×
Price / book	1.8×+0.9×	1.1×+0.2×	1×+0.2×	0.8×-0.1×	0.9×0.0×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Vir Biotechnology, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Vir Biotechnology, Inc.'s profit margins?: Vir Biotechnology, Inc. (VIR) runs a 96.1% gross margin and a -720.8% operating margin, with a -676.0% net margin.
Where do Vir Biotechnology, Inc.'s ratios come from?: Every ratio is computed from Vir Biotechnology, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.